Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
2/1/1989
1.
Phase III Trial of ICS 205-930 vs a Metoclopramide-Containing Antiemetic Cocktail for the Prevention of Cisplatin-Induced Emesis in Patients with non-Small Cell Lung Cancer or Cancer of the Head and Neck (Summary Last Modified 02/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
over 18
EORTC-08881
2.
Phase I/II Regional Chemotherapy with CACP/DCM for Advanced Head and Neck Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
NCI
UAB-154
NCI-T83-1229D, T83-1229
3.
Phase I/II Comparative Evaluation of Continuous vs Intermittent CACP in Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
15 and over
MDA-DM-8490
NCI-V85-0135
Last Modified:
2/1/1991
4.
Phase I/II Study of Escalating Single Doses of Metoclopramide Given in Combination with Dexamethasone and Lorazepam for the Control of Cisplatin-Induced Nausea and Vomiting (Summary Last Modified 02/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Supportive care
Completed
30 and over
MSKCC-88074
NCI-V88-0580
Last Modified:
7/1/1990
5.
Randomized Study of a Triple Antiemetic Combination Suppository Containing Metoclopramide/Dexamethasone/Diphenhydramine for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Summary Last Modified 07/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Closed
18 to 70
UKMC-87GYN03
NCI-V88-0455
Last Modified:
11/1/1992
6.
Evaluation of MDLO (Metoclopramide/Dexamethasone/Lorazepam/Ondansetron) for the Prevention of Acute Vomiting In Cancer Patients Receiving High-Dose Cisplatin (Summary Last Modified 11/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Closed
18 and over
MSKCC-91072
NCI-V91-0180
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute